Jiangxi: Johnson & Johnson, Bard was named! Cancellation
Medical Network June 25th The price of 26 high-value consumable products was canceled due to the failure to report prices honestly, involving 15 companies, including Budd and Johnson & Johnson (Shanghai).
On June 22, the Jiangxi Provincial Pharmaceutical Purchase Service Platform issued the “Circular on Announcement of the Dispatch Resolution Concerning the Release of High Value Medical Consumables for Centralized Net Procurement” (hereinafter referred to as the “Notice”). The “Notice” stated that supplements for high-value medical supplies were added. During the publicity of the results of the registration and verification, the company received complaints from some companies, and after investigation and verification, reported that the Jiangxi Provincial Health and Planning Commission Medical Consumables Concentrated Procurement Leading Group Office had made a study and decided to cancel 15 consumables companies that did not report their prices honestly. Hanging network qualification.
In the 15 companies, Bader Medical Equipment (Shanghai) Co., Ltd. found that the price of an imported non-anti-adhesion patch product was falsely canceled; the Johnson & Johnson (Shanghai) Medical Equipment Co., Ltd. Due to an orthopedic consumables and an absorbable clip, the price was falsely disqualified. Of the 15 disqualified companies, 19 imported consumables and 7 domestic consumables were involved.
Shanghai Ruigu Biotechnology Co., Ltd.'s 5 'Other Synthetic Bone' products, quotations ranging from 2460 yuan to 10050 yuan, are treated as not faithful reporting prices.
May 16, 2018, Jiangxi Province medicine The Procurement Service Platform released the "2018 Jiangxi Provincial Public Appraisal Form for Auditing Product Information for Supplementary Registration of High-value Medical Supplies." A total of 6025 high-value consumable products passed the review. During the one-week publicity period, a total of 252 products had objections. The processing results include: Linking to the fourth-grade directory, canceling the qualifications for the online connection; Disqualifying the application for cancellation of online screening; Not revoking the linked network in the scope of centralized procurement. Medtronic (Shanghai) Management Co., Ltd. may not register due to the penalty period.
enterprise False quotation is the old and difficult problem of consumables collection. According to the Jiangxi Provincial Health and Planning Commission issued on May 11, 2016, “Jiangxi Provincial Public Medical Institutions Concentrate the High Value Medical Consumables Online. purchase Implementation Plan, The set price reference for consumables collection and procurement is based on the current bidding price of medical consumables in each province (city, district); the current actual purchase price of medical institutions in Jiangxi Province and municipalities.
For price-free basis, according to the clinical needs of the medical institutions, after successful negotiation with the enterprise, the provincial medical procurement service platform will be included in the procurement directory of medical institutions.
The same auction group product uses the lowest value of the following price of the company as the reference price: the lowest price of the centralized bidding purchase price in each province (city, district); the lowest price of the actual purchase price of the provincial and municipal medical institutions.
During the period of reference price publicity, publicity is included in the catalogue of purchases on-line without any objection. When a medical institution negotiates for a price, it will be consulted. If verified to provide false price information, the product's eligibility for the product will be cancelled.
